Brief: Aileron Therapeutics - On April 25, 2022, Richard J. Wanstall, CFO, Notified Company Of His Resignation, Effective May 6, 2022
29/04/2022 22:57
April 29 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS - ON APRIL 25, 2022, RICHARD J.
WANSTALL,
CFO, NOTIFIED COMPANY OF HIS RESIGNATION, EFFECTIVE MAY 6, 2022
* AILERON THERAPEUTICS INC - HAS INITIATED A SEARCH PROCESS
FOR
POSITION OF CHIEF FINANCIAL OFFICER OF COMPANY
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering